顯示第 225 至 240 項結果,共 450 項
-
Anti-IGF1R [10H5] (Ab02740-1.1)
-
Anti-IL-12/23 [ABT-874 (Briakinumab)] (Ab00722-2.0-BT)
-
Anti-IL-12/23 [ABT-874 (Briakinumab)] (Ab00722-2.0)
-
Anti-IL-2 [UFKA-20] (Ab02947-3.0)
-
Anti-IL-2 [UFKA-20] (Ab02947-3.3)
-
Anti-IL-21R [ATR-107] (Ab01293-2.0-BT)
-
Anti-IL-21R [ATR-107] (Ab01293-2.0)
-
Anti-IL-21R [ATR-107] (Ab01293-2.3-BT)
-
Anti-IL-21R [ATR-107] (Ab01293-2.3)
-
Anti-IL-2R [Daclizumab] (Ab00187-1.1-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-1.1)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-2.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-2.0)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-3.0-BT)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-3.0)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-3.3-BT)
